Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss patterns differ between males and females due to 5 master regulators and JAK-STAT signaling affects hair growth.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Lack of 5α-Reductase type 1 can lead to insulin resistance and liver problems.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

High androgen levels and genetic factors likely cause Becker's nevus and related symptoms.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

TMPRSS2 is crucial for COVID-19 infection and is a potential target for treatment.

Epigenetic changes might protect occipital hair from male pattern baldness.

Future treatments for androgenic alopecia may focus on reactivating hair follicle stem cells and improving drug delivery.

A 21-year-old male with a rare genetic disorder experienced sudden hair loss and high DHEAS levels, likely due to a condition similar to PCOS, usually seen in women.

Alopecia and acne in women are complex conditions needing coordinated care and personalized treatment.

Male pattern baldness is partly caused by specific genes, but most genetic factors are still unknown.

CAG repeat numbers in the AR gene likely don't affect male pattern baldness in Korean men.

Most severe COVID-19 patients had hair loss, suggesting a possible link.

Hair loss increases with age and is triggered by hormones like androgens.

Androgen effects on hair follicles vary by skin area.

Both genes and environmental factors like chemicals may contribute to the increase in hypospadias, but the exact causes are still unclear.

Low and ultralow doses of flutamide can cause liver damage in young women with high androgen levels, regardless of dose or birth control use, with higher risk for those with higher BMI and liver enzyme levels before treatment.

Androgenetic alopecia is influenced by multiple genes and pathways, with genetic risk varying by population, and personalized treatments are being explored.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

Androgens play a key role in hair growth and disorders like baldness and excessive hairiness.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Early onset hair loss linked to genetics and androgen levels.

Androgens may cause hair loss by increasing TGF-beta1 from scalp cells, which inhibits hair cell growth.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.